A mesenchymal stromal cell line resistant to paclitaxel that spontaneously differentiates into osteoblast-like cells

Cell Biology and Toxicology

Volumn 27, Issue 3, 2011, Pages 169-180

  Pessina, Augusto ^a   Sisto, Francesca ^a   Coccè, Valentina ^a   Cavicchini, Loredana ^a   Ciusani, Emilio ^b   Gribaldo, Laura ^c   Bonomi, Arianna ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c JOINT RESEARCH CENTRE   (Italy)

Author keywords

Drug sensitivity; Mesenchymal stem cells; Osteogenesis; Paclitaxel resistance; SR 4987

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P; HISTONE DEACETYLASE INHIBITOR; INDOMETACIN; PACLITAXEL; VALPROIC ACID; VERAPAMIL;

ANIMAL CELL; ARTICLE; BONE MARROW; CANCER CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL STRAIN HT29; CELL STRAIN MOLT 4; CELL STRAIN SR 4987; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYME CELL; MOUSE; MOUSE STRAIN; NONHUMAN; OSTEOBLAST; PATHOPHYSIOLOGY; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

ADIPOCYTES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASPIRIN; BONE MARROW CELLS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHONDROCYTES; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; INDOMETHACIN; MESENCHYMAL STEM CELLS; MICE; OSTEOBLASTS; P-GLYCOPROTEIN; PACLITAXEL; VALPROIC ACID;

MUS;

EID: 79959726421     PISSN: 07422091     EISSN: 15736822     Source Type: Journal    
DOI: 10.1007/s10565-010-9179-x     Document Type: Article

References (35)

1. Burns BS, Edin ML, Lester GE, Tuttle HG, Wall ME, Wani MC, et al. Selective drug resistant human osteosarcoma cell lines. Clin Orthop Relat Res. 2001;383:259-67. (Pubitemid 32126171)
2. Chang JK, Li CJ, Wu SC, Yeh CH, Chen CH, Fu YC, et al. Effects of anti-inflammatory drugs on proliferation, cytotoxicity and osteogenesis in bone marrow mesenchymal stem cells. Biochem Pharmacol. 2007;74:1371-82.
3. Cho HH, Park HT, Kim YJ, Bae YC, Suh KT, Jung JS. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. J Cell Biochem. 2005;96:533-42. (Pubitemid 41504651)
4. Dennis JE, Merriam A, Awadallah A, Yoo JU, Johnstone B, Caplan AI. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res. 1999;14:700-9. (Pubitemid 29210596)
5. Fogh J, Trempe G. New human tumor cell lines. In: Fogh J, editor. Human tumor cells in vitro. New York: Plenum; 1975. p. 115-41.
6. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966;16:381-90.
7. Gribaldo L, Catalani P, Erminio M. Metabolism of doxorubicin in long-term bone marrow cultures and SR-4987 stromal established cell line. Drug Metab Drug Interact. 1999;15:279-91.
8. Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone. 1992;13:69-80.
9. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998;238:265-72.
10. Kellinsalmi M, Parikka V, Risteli J, Hentunen T, Leskelä HV, Lehtonen S, et al. Inhibition of cyclooxygenase-2 downregulates osteoclast and osteoblast differentiation and favours adipocyte formation in vitro. Eur J Pharmacol. 2007;572:102-10. (Pubitemid 47429646)
11. McAteer JA, Devis J. Basic cell culture technique and the maintenance of cell lines. In: Davis JM, editor. Basic cell culture. Oxford: Oxford University Press; 1994. p. 93-148.
12. Minowada J, Onuma T, Moore GE. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst. 1972;49:891-5.
13. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth. 1983;65:55-63.
14. Opavsky R, Haviernik P, Jurkovicova D, Garin MT, Copeland NG, Gilbert DJ, et al. Molecular characterization of the mouse Tem1/endosialin gene regulated by cell density in vitro and expressed in normal tissues in vivo. J Biol Chem. 2001;276:38795-807.
15. Orr GA, Verdier-Pinard P, McDaid H, Horwitz SB. Mechanisms of Taxol resistance related to microtubules. Oncogene. 2003;22:7280-95. (Pubitemid 37487160)
16. Parekh H, Wiesen K, Simpkins H. Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells. Biochem Pharmacol. 1997;53:461-70. (Pubitemid 27149538)
17. Pessina A, Mineo E, Neri MG, Gribaldo L, Colombi R, Brambilla P, et al. Establishment and characterization of a new murine cell line (SR-4987) derived from marrow stromal cells. Cytotechnology. 1992;8:93-102.
18. Pessina A, Gribaldo L, Mineo E, Neri MG. In vitro short-term and long-term cytotoxicity of fluoroquinolones on murine cell lines. Ind J Exp Biol. 1994;32:113-8.
19. Pessina A, Piccirillo M, Mineo E, Tassi E, Brambilla P, Neri MG. A simple quantitative bioassay for basic fibroblast growth factor using SR-4987 cells as target. Methods Mol Cell Biol. 1995;5:230-6.
20. Pessina A, Neri MG, Mineo E, Piccirillo M, Gribaldo L, Brambilla P, et al. Expression of B cell markers on SR-4987 cells derived from murine marrow stroma. Exp Hematol. 1997;25:536-41. (Pubitemid 27293517)
21. Pessina A, Mineo E, Neri MG, Piccirillo M, Valore L, Giuliani A. SR-4987 and L1210 cell lines: two models in which cholera toxin susceptibility does not correlate with cAMP accumulation and ganglioside content. Cell Mol Biol. 1998;44:933-40.
22. Pessina A, Piccirillo M, Mineo E, Catalani P, Gribaldo L,Marafante E, et al. Role of SR-4987 stromal cells in the modulation of doxorubicin toxicity to in vitro granulocyte-macrophage progenitors (CFU-GM). Life Sci. 1999;655:513-23. (Pubitemid 29342433)
23. Pessina A, Eletti B, Croera C, Savalli N, Diodovich C, Gribaldo L. Pancreas developing markers expressed on human mononucleated umbilical cord blood cells. Biochem Biophys Res Commun. 2004;323:315-22. (Pubitemid 39200684)
24. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-7. (Pubitemid 29282067)
25. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Epidemiol. 1938;27:493-7.
26. Røsland GV, Svendsen A, Torsvik A, Sobala E, McCormack E, Immervoll H, et al. Long-term cultures of bone marrowderived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 2009;69:5331-9.
27. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature. 1979;277:665-7. (Pubitemid 9114288)
28. Synold TW, Dussault I, Forman BM. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med. 2001;7:584-90. (Pubitemid 32448326)
29. Takagi M. Cell processing engineering for ex-vivo expansion of hematopoietic cells. J Biosci Bioeng. 2005;99:189-96. (Pubitemid 40570077)
30. Takagi M, Sasaki T, Yoshida T. Spatial development of the cultivation of a bone marrow stromal cell line in porous carriers. Cytotechnology. 1999;31:225-31. (Pubitemid 29514375)
31. Tallheden T, Dennis JE, Lennon DP, Sjögren-Jansson E, Caplan AI, Lindahl A. Phenotypic plasticity of human articular chondrocytes. J Bone Joint Surg Am. 2003;85:93-100. (Pubitemid 36535050)
32. Tropel P, Noe D, Platet N, Legrand P, Benabid AL, Berbera F. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res. 2004;295:395-406. (Pubitemid 38490494)
33. Ulmanen M, Birr E,Hietala O, Lindholm TS. Determination of the biological activity of BMPs in cell cultures is unreliable. In: Lindholm TS, editor. Advances in skeletal reconstruction using bone morphogenetic proteins. Singapore: World Scientific; 2002. p. 53-61.
34. Wang Y, Chen X, Zhu W, Zhang H, Hu S, Cong X. Growth inhibition of mesenchymal stem cells by aspirin: involvement of the WNT/beta-catenin signal pathway. Clin Exp Pharmacol Physiol. 2006;33:696-701. (Pubitemid 44060760)
35. Yamaza T, Miura Y, Bi Y, Liu Y, Akiyama K, Sonoyama W, et al. Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. PLoS ONE. 2008;3:e2615.